| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cell, Tumor, and Stem Cell Biology |
1Division of Digestive Diseases, Department of Medicine, 2Department of Pharmacology, and 3Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia
* To whom correspondence should be addressed. E-mail: vyang{at}emory.edu.
| Abstract |
|---|
Inactivation of the tumor suppressor adenomatous polyposis coli, with the resultant activation of
-catenin, is the initiating event in the development of a majority of colorectal cancers. Krüppel-like factor 5 (KLF5), a proproliferative transcription factor, is highly expressed in the proliferating intestinal crypt epithelial cells. To determine whether KLF5 contributes to intestinal adenoma formation, we examined tumor burdens in ApcMin/+ mice and ApcMin/+/Klf5+/- mice. Compared with ApcMin/+ mice, ApcMin/+/Klf5+/- mice had a 96% reduction in the number of intestinal adenomas. Reduced tumorigenicity in the ApcMin/+/Klf5+/- mice correlated with reduced levels and nuclear localization of
-catenin as well as reduced expression of two
-catenin targets, cyclin D1 and c-Myc. In vitro studies revealed a physical interaction between KLF5 and
-catenin that enhanced the nuclear localization and transcriptional activity of
-catenin. Thus, KLF5 is necessary for the tumor-initiating activity of
-catenin during intestinal adenoma formation in ApcMin/+ mice, and reduced expression of KLF5 offsets the tumor-initiating activity of the ApcMin mutation by reducing the nuclear localization and activity of
-catenin. [Cancer Res 2009;69(10):4125–33]
Key Words:
KLF5, APC, adenomas, colorectal cancer,
-catenin
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |